Cargando…
HER1-Targeted (86)Y-Panitumumab Possesses Superior Targeting Characteristics than (86)Y-Cetuximab for PET Imaging of Human Malignant Mesothelioma Tumors Xenografts
Malignant mesothelioma (MM), a rare form of cancer is often associated with previous exposure to fibrous minerals, such as asbestos. Asbestos exposure increases HER1-activity and expression in pre-clinical models. Additionally, HER1 over-expression is observed in the majority of MM cases. In this st...
Autores principales: | Nayak, Tapan K., Garmestani, Kayhan, Milenic, Diane E., Baidoo, Kwamena E., Brechbiel, Martin W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3064677/ https://www.ncbi.nlm.nih.gov/pubmed/21464917 http://dx.doi.org/10.1371/journal.pone.0018198 |
Ejemplares similares
-
In vitro and in vivo pre-clinical analysis of a F(ab')(2 )fragment of panitumumab for molecular imaging and therapy of HER1-positive cancers
por: Wong, Karen J, et al.
Publicado: (2011) -
Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab
por: Milenic, Diane E., et al.
Publicado: (2017) -
In Vitro and In Vivo Analysis of Indocyanine
Green-Labeled Panitumumab for Optical Imaging—A Cautionary
Tale
por: Zhou, Yang, et al.
Publicado: (2014) -
Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from (177)Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts
por: Yong, Kwon Joong, et al.
Publicado: (2016) -
Impact of α-Targeted Radiation Therapy on Gene Expression in a Pre-Clinical Model for Disseminated Peritoneal Disease when Combined with Paclitaxel
por: Yong, Kwon Joong, et al.
Publicado: (2014)